4.5 Review

Microbiota-targeted therapies in inflammation resolution

期刊

SEMINARS IN IMMUNOLOGY
卷 59, 期 -, 页码 -

出版社

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.smim.2022.101599

关键词

Gut microbiome; Inflammation; Probiotics; FMT; Mucosal immunity; Live biotherapeutic products

资金

  1. AIRC IG [IG-22923]
  2. Italy's Ministry of Health [GR-2016-0236174]

向作者/读者索取更多资源

The gut microbiota plays a significant role in immune regulation, health, and disease. An imbalance in the gut microbiota can lead to inflammation and the development of various diseases. Current research focuses on understanding the interaction between the host and microbes, and exploring new methods to manipulate the microbiota to restore health and prevent inflammatory conditions.
Gut microbiota has been shown to systemically shape the immunological landscape, modulate homeostasis and play a role in both health and disease. Dysbiosis of gut microbiota promotes inflammation and contributes to the pathogenesis of several major disorders in gastrointestinal tract, metabolic, neurological and respiratory diseases. Much effort is now focused on understanding host-microbes interactions and new microbiota-targeted therapies are deeply investigated as a means to restore health or prevent disease. This review details the immunoregulatory role of the gut microbiota in health and disease and discusses the most recent strategies in manipulating individual patient's microbiota for the management and prevention of inflammatory conditions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据